Cardiac transplantation: a review

Area of Science:

• Cardiology
• Transplantation Medicine
• Immunology

Background:

• Cardiac transplantation is an established therapy for end-stage heart failure.
• Current 5-year and 10-year survival rates are 67% and 52%, respectively.
• Graft coronary occlusive disease, rejection, and infection remain significant challenges.

Purpose of the Study:

• To review donor and recipient selection criteria for cardiac transplantation.
• To summarize current and emerging immunosuppressive strategies.
• To discuss major complications including infection, rejection, nephrotoxicity, and graft coronary occlusive disease.

Main Methods:

• Literature review of cardiac transplantation.
• Analysis of donor and recipient selection criteria.
• Overview of immunosuppressive protocols and agents.
• Summary of post-transplant complications.

Main Results:

• Cardiac transplantation survival rates are improving but limited by specific complications.
• Effective immunosuppression is crucial for preventing rejection.
• Infection and graft coronary occlusive disease significantly impact long-term survival.

Conclusions:

• Cardiac transplantation is a definitive treatment for end-stage heart failure.
• Ongoing research focuses on optimizing immunosuppression and managing complications.
• Further advancements are needed to improve long-term graft survival and patient outcomes.